Mikiro Takaishi

Suggest Changes
Learn More
BACKGROUND Targeting the IL-17 pathway represents a highly effective strategy for the treatment of psoriasis, using antibodies against IL-17A and IL-17 receptor, suggesting that Th17 cells(More)
Recently, we demonstrated that S100C/A11 comprises an essential pathway for growth suppression by TGFβ in normal human keratinocytes. Nuclear transfer of S100C/A11 was a hallmark of the activation of(More)